BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 22669255)

  • 1. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
    Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C
    Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ⁶⁸Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results.
    Afshar-Oromieh A; Wolf MB; Kratochwil C; Giesel FL; Combs SE; Dimitrakopoulou-Strauss A; Gnirs R; Roethke MC; Schlemmer HP; Haberkorn U
    Neuro Oncol; 2015 Feb; 17(2):312-9. PubMed ID: 25008094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series.
    Graf R; Plotkin M; Steffen IG; Wurm R; Wust P; Brenner W; Budach V; Badakhshi H
    Head Face Med; 2012 Jan; 8():1. PubMed ID: 22217329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of
    Stade F; Dittmar JO; Jäkel O; Kratochwil C; Haberkorn U; Debus J; Combs SE
    Radiat Oncol; 2018 Apr; 13(1):58. PubMed ID: 29606149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
    Milker-Zabel S; Zabel-du Bois A; Henze M; Huber P; Schulz-Ertner D; Hoess A; Haberkorn U; Debus J
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):222-7. PubMed ID: 16488553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of 68Ga-DOTATOC PET/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy.
    Graf R; Nyuyki F; Steffen IG; Michel R; Fahdt D; Wust P; Brenner W; Budach V; Wurm R; Plotkin M
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):68-73. PubMed ID: 22575489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas.
    Nyuyki F; Plotkin M; Graf R; Michel R; Steffen I; Denecke T; Geworski L; Fahdt D; Brenner W; Wurm R
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):310-8. PubMed ID: 19763565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.
    Acker G; Kluge A; Lukas M; Conti A; Pasemann D; Meinert F; Anh Nguyen PT; Jelgersma C; Loebel F; Budach V; Vajkoczy P; Furth C; Baur ADJ; Senger C
    Neurosurg Focus; 2019 Jun; 46(6):E9. PubMed ID: 31153151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
    Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J
    Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of diagnostic value of 68 Ga-DOTATOC PET/MRI and standalone MRI for the detection of intracranial meningiomas.
    Einhellig HC; Siebert E; Bauknecht HC; Tietze A; Graef J; Furth C; Schulze D; Miszczuk M; Bohner G; Schatka I; Makowski MR
    Sci Rep; 2021 Apr; 11(1):9064. PubMed ID: 33907204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of [
    Milosevic A; Styczen H; Grueneisen J; Li Y; Weber M; Fendler WP; Kirchner J; Damman P; Wrede K; Lazaridis L; Glas M; Guberina M; Eckstein A; Blau T; Herrmann K; Umutlu L; Forsting M; Deuschl C; Schaarschmidt B
    J Nucl Med; 2023 Aug; 64(8):1185-1190. PubMed ID: 37385668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience.
    Thorwarth D; Henke G; Müller AC; Reimold M; Beyer T; Boss A; Kolb A; Pichler B; Pfannenberg C
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):277-83. PubMed ID: 21300465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.
    Gehler B; Paulsen F; Oksüz MO; Hauser TK; Eschmann SM; Bares R; Pfannenberg C; Bamberg M; Bartenstein P; Belka C; Ganswindt U
    Radiat Oncol; 2009 Nov; 4():56. PubMed ID: 19922642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of
    Sawicki LM; Deuschl C; Beiderwellen K; Ruhlmann V; Poeppel TD; Heusch P; Lahner H; Führer D; Bockisch A; Herrmann K; Forsting M; Antoch G; Umutlu L
    Eur Radiol; 2017 Oct; 27(10):4091-4099. PubMed ID: 28439648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas.
    Dittmar JO; Kratochwil C; Dittmar A; Welzel T; Habermehl D; Rieken S; Giesel FL; Haberkorn U; Debus J; Combs SE
    Radiat Oncol; 2017 Nov; 12(1):169. PubMed ID: 29110720
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kowalski ES; Khairnar R; Gryaznov AA; Kesari V; Koroulakis A; Raghavan P; Chen W; Woodworth G; Mishra M
    Radiat Oncol; 2021 Aug; 16(1):151. PubMed ID: 34399805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.
    Schraml C; Schwenzer NF; Sperling O; Aschoff P; Lichy MP; Müller M; Brendle C; Werner MK; Claussen CD; Pfannenberg C
    Cancer Imaging; 2013 Mar; 13(1):63-72. PubMed ID: 23466785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Detection of Transosseous Meningiomas Using
    Kunz WG; Jungblut LM; Kazmierczak PM; Vettermann FJ; Bollenbacher A; Tonn JC; Schichor C; Rominger A; Albert NL; Bartenstein P; Reiser MF; Cyran CC
    J Nucl Med; 2017 Oct; 58(10):1580-1587. PubMed ID: 28450556
    [No Abstract]   [Full Text] [Related]  

  • 19. The usefulness of [
    Wang P; Liu S; Li X; Liu X; Li S; Wu Z; Cheng X
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):218-225. PubMed ID: 37682301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours.
    Schreiter NF; Brenner W; Nogami M; Buchert R; Huppertz A; Pape UF; Prasad V; Hamm B; Maurer MH
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):72-82. PubMed ID: 21927931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.